Boris Kantor - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	1
2008	1
2009	1
2010	2
2011	2
2012	1
2014	2
2017	3
2018	1
2019	1
2020	5
2021	5
2022	1
2023	1
2024	1

1

Clinical applications involving CNS gene transfer.

Kantor B, McCown T, Leone P, Gray SJ. Kantor B, et al. Adv Genet. 2014;87:71-124. doi: 10.1016/B978-0-12-800149-3.00002-0. Adv Genet. 2014. PMID: 25311921 Free PMC article. Review.

2

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.

Dong W, Kantor B. Dong W, et al. Among authors: kantor b. Viruses. 2021 Jul 1;13(7):1288. doi: 10.3390/v13071288. Viruses. 2021. PMID: 34372494 Free PMC article. Review.

3

Methods for gene transfer to the central nervous system.

Kantor B, Bailey RM, Wimberly K, Kalburgi SN, Gray SJ. Kantor B, et al. Adv Genet. 2014;87:125-97. doi: 10.1016/B978-0-12-800149-3.00003-2. Adv Genet. 2014. PMID: 25311922 Free PMC article. Review.

4

The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.

MacDougall G, Brown LY, Kantor B, Chiba-Falek O. MacDougall G, et al. Among authors: kantor b. Mol Ther. 2021 Mar 3;29(3):949-972. doi: 10.1016/j.ymthe.2021.01.001. Epub 2021 Jan 9. Mol Ther. 2021. PMID: 33429080 Free PMC article. Review.

5

Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies.

Sun Z, Kantor B, Chiba-Falek O. Sun Z, et al. Among authors: kantor b. Mol Ther Nucleic Acids. 2023 Nov 24;35(1):102084. doi: 10.1016/j.omtn.2023.102084. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2023. PMID: 38130373 Free PMC article.

6

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's.

Yang A, Kantor B, Chiba-Falek O. Yang A, et al. Among authors: kantor b. Int J Mol Sci. 2021 Jan 27;22(3):1244. doi: 10.3390/ijms22031244. Int J Mol Sci. 2021. PMID: 33513969 Free PMC article. Review.

7

Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future Directions.

Uchitel J, Kantor B, Smith EC, Mikati MA. Uchitel J, et al. Among authors: kantor b. Pediatr Neurol. 2020 Sep;110:5-19. doi: 10.1016/j.pediatrneurol.2020.04.010. Epub 2020 Apr 24. Pediatr Neurol. 2020. PMID: 32684374 Review.

8

Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs.

Rittiner J, Cumaran M, Malhotra S, Kantor B. Rittiner J, et al. Among authors: kantor b. Front Bioeng Biotechnol. 2022 Oct 17;10:1035543. doi: 10.3389/fbioe.2022.1035543. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324900 Free PMC article. Review.

9

DNA methylation in epigenetic control of gene expression.

Razin A, Kantor B. Razin A, et al. Among authors: kantor b. Prog Mol Subcell Biol. 2005;38:151-67. doi: 10.1007/3-540-27310-7_6. Prog Mol Subcell Biol. 2005. PMID: 15881894 Review.

10

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease.

Angrist M, Yang A, Kantor B, Chiba-Falek O. Angrist M, et al. Among authors: kantor b. Life Sci Soc Policy. 2020 Oct 12;16(1):11. doi: 10.1186/s40504-020-00106-2. Life Sci Soc Policy. 2020. PMID: 33043412 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year